植物医生IPO冲刺深交所主板，生物多样性保护赋能国货美妆可持续发展

Core Viewpoint - DR PLANT, a domestic brand focused on high-altitude plant skincare, is progressing towards its IPO on the Shenzhen Stock Exchange, reflecting its commitment to balancing commercial value and social responsibility [1] Group 1: IPO Progress - The IPO status of DR PLANT has been updated to "inquired" as of November 21, 2025, indicating a significant step towards its public listing [1] - The brand aims to leverage its IPO to enhance its market presence and further its mission of biodiversity protection [4] Group 2: Commitment to Biodiversity - DR PLANT integrates biodiversity protection into its brand DNA, emphasizing the philosophy of "taking from nature and giving back to nature" [2] - The brand has initiated various biodiversity protection actions, including the "Biodiversity - High Mountain Plant Protection Action" launched in 2017 [2] - As of now, DR PLANT has successfully restored 5,590 acres of high-altitude ecological environment in Yunnan [2] Group 3: International Collaboration - In October 2020, DR PLANT signed a partnership with the United Nations Development Programme (UNDP) to enhance its biodiversity protection efforts on an international scale [3] - The collaboration marks a significant step in the brand's commitment to global environmental initiatives [3] Group 4: Business and Philanthropy Synergy - The brand's strategy of utilizing high-altitude plants for skincare aligns with its biodiversity protection efforts, creating a sustainable cycle of business and philanthropy [4] - DR PLANT has established a professional R&D system, resulting in 223 patents, including 68 invention patents, showcasing its innovation in skincare products [4] - The "protection-research-transformation" model not only differentiates the brand in the market but also provides ongoing support for its philanthropic initiatives [4]